CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 105 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,201,742 | +40.1% | 45,868 | +5.1% | 0.06% | +88.2% |
| Q3 2022 | $858,000 | +387.5% | 43,634 | +333.8% | 0.03% | +325.0% |
| Q2 2022 | $176,000 | -61.8% | 10,059 | -64.3% | 0.01% | -60.0% |
| Q1 2022 | $461,000 | +112.4% | 28,200 | +65.9% | 0.02% | +25.0% |
| Q3 2021 | $217,000 | – | 17,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |